Chapter 22 : Evolution of : New Insights into Pathogenicity and Drug Resistance

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Zoom in

Evolution of : New Insights into Pathogenicity and Drug Resistance, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555819569/9781555819552_Chap22-1.gif /docserver/preview/fulltext/10.1128/9781555819569/9781555819552_Chap22-2.gif


The evolution of toward one of the most dangerous human pathogens is of particular interest for the analysis of the continued importance of tuberculosis as a global disease. While the majority of mycobacterial species are harmless environmental bacteria, is able to induce pulmonary lesions and disease in the human host, which represents an essential step for the aerosol transmission of the bacterium to new individuals. The question of when and where or one of its progenitors has acquired this faculty has interested scientists for years. It is hypothesized that the ancestors of once had an environmental reservoir and gradually evolved to adapt to the life within host cells, leading finally to the feature of getting transmitted from one host to another ( ). First insights into this issue can be obtained from genomic comparison of with related nontuberculous mycobacteria (NTM), also known as atypical mycobacteria or mycobacteria other than tuberculosis (MOTT). Based on 16S rRNA sequence similarity, and were the currently known closest relatives of ( ). In a later study, based on whole-genome sequencing (WGS), was found as the closest NTM species of ( ), whereas a different WGS study designated / as most closely related to , followed by a subgroup containing , , and ( ). However, despite the similarities at the DNA and protein level, the genome size differences between the closest NTM species relative to are considerable ( ). strains harbor a 4.4 MB genome ( ), whereas the genomes of , , and are larger in size (6.7, 6.4, and 5.8 MB, respectively) ( ). In contrast, the genomes of , , and are smaller in size (4.2, 3.3, and 3.3 MB, respectively) ( ), whereby the strong size reduction of the latter two species is due to a common, extensive phase of reductive evolution ( ). It seems conceivable that the individual adaptations of the different mycobacterial species to specific environmental conditions went along with genome downsizing, gene acquisition through horizontal gene transfer, genome rearrangements, and/or recombination.

Citation: Boritsch E, Brosch R. 2017. Evolution of : New Insights into Pathogenicity and Drug Resistance, p 495-515. In Jacobs, Jr. W, McShane H, Mizrahi V, Orme I (ed), Tuberculosis and the Tubercle Bacillus, Second Edition. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.TBTB2-0020-2016
Highlighted Text: Show | Hide
Loading full text...

Full text loading...


Image of Figure 1
Figure 1

Scheme showing supposed molecular key events in mycobacterial evolution from a recombinogenic strain pool toward professional pathogens of mammalian hosts. Network phylogeny inferred among eight strains and 46 selected genome sequences from MTBC members by NeighborNet analysis. Pairwise alignments of whole genome SNP data are the basis of the calculation. Recombination of and deletion of in a potential progenitor of the MTBC strains illustrated in the inset. Figure reproduced from reference .

Citation: Boritsch E, Brosch R. 2017. Evolution of : New Insights into Pathogenicity and Drug Resistance, p 495-515. In Jacobs, Jr. W, McShane H, Mizrahi V, Orme I (ed), Tuberculosis and the Tubercle Bacillus, Second Edition. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.TBTB2-0020-2016
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 2
Figure 2

Neighbor-joining phylogeny scheme based on variable nucleotide positions with main focus on tubercle bacilli that have a human host preference, using as root of the tree (after reference ). The filtered SNPs refer to the mutations identified between the various strains relative to H37Rv ( ). Figure reproduced from reference .

Citation: Boritsch E, Brosch R. 2017. Evolution of : New Insights into Pathogenicity and Drug Resistance, p 495-515. In Jacobs, Jr. W, McShane H, Mizrahi V, Orme I (ed), Tuberculosis and the Tubercle Bacillus, Second Edition. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.TBTB2-0020-2016
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 3
Figure 3

Overview of a large number of potential drug resistance as well as compensatory mutations against first- and second-line drugs. Mutations shown in bold represent most commonly found mutations among resistant strains. Semibold secondary mutations in , and were found to be shared by related strains, thus suggesting mutations favoring transmission. Any mutations leading to at least rifampin and isoniazid resistance confer an MDR phenotype, whereas MDR strains with additional mutations against at least one of the three injectable drugs, kanamycin, amikacin, and capreomycin, and to any fluoroquinolone used against are referred to as XDR strains. Table based on mutations found in the following publications ( ).

Citation: Boritsch E, Brosch R. 2017. Evolution of : New Insights into Pathogenicity and Drug Resistance, p 495-515. In Jacobs, Jr. W, McShane H, Mizrahi V, Orme I (ed), Tuberculosis and the Tubercle Bacillus, Second Edition. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.TBTB2-0020-2016
Permissions and Reprints Request Permissions
Download as Powerpoint
Image of Figure 4
Figure 4

Suggested model for a selection bottleneck followed by random mutations on the population structure of clinical isolates. Genetic diversity of subpopulations is present in a rifampin monoresistant clinical isolate (each individual bacterium contains a rifampin resistance-conferring mutation). Upon isoniazid treatment clones carrying low-cost resistance mutations to the drug become dominant and prevail over other variants, resulting in the loss of numerous other genetic mutations. Subsequent repeated genetic diversification results in genomic heterogeneity of the MDR strain population. x represents an isoniazid resistance-causing mutation. Figure adapted from reference .

Citation: Boritsch E, Brosch R. 2017. Evolution of : New Insights into Pathogenicity and Drug Resistance, p 495-515. In Jacobs, Jr. W, McShane H, Mizrahi V, Orme I (ed), Tuberculosis and the Tubercle Bacillus, Second Edition. ASM Press, Washington, DC. doi: 10.1128/microbiolspec.TBTB2-0020-2016
Permissions and Reprints Request Permissions
Download as Powerpoint


1. Koeck JL,, Fabre M,, Simon F,, Daffé M,, Garnotel E,, Matan AB,, Gérôme P,, Bernatas JJ,, Buisson Y,, Pourcel C . 2011. Clinical characteristics of the smooth tubercle bacilli ‘ Mycobacterium canettii’ infection suggest the existence of an environmental reservoir. Clin Microbiol Infect 17 : 1013 1019. [CrossRef] [CrossRef]
2. Supply P,, Marceau M,, Mangenot S,, Roche D,, Rouanet C,, Khanna V,, Majlessi L,, Criscuolo A,, Tap J,, Pawlik A,, Fiette L,, Orgeur M,, Fabre M,, Parmentier C,, Frigui W,, Simeone R,, Boritsch EC,, Debrie AS,, Willery E,, Walker D,, Quail MA,, Ma L,, Bouchier C,, Salvignol G,, Sayes F,, Cascioferro A,, Seemann T,, Barbe V,, Locht C,, Gutierrez MC,, Leclerc C,, Bentley SD,, Stinear TP,, Brisse S,, Médigue C,, Parkhill J,, Cruveiller S,, Brosch R . 2013. Genomic analysis of smooth tubercle bacilli provides insights into ancestry and pathoadaptation of Mycobacterium tuberculosis . Nat Genet 45 : 172 179. [CrossRef] [CrossRef]
3. Springer B,, Stockman L,, Teschner K,, Roberts GD,, Böttger EC . 1996. Two-laboratory collaborative study on identification of mycobacteria: molecular versus phenotypic methods. J Clin Microbiol 34 : 296 303.
4. Veyrier F,, Pletzer D,, Turenne C,, Behr MA . 2009. Phylogenetic detection of horizontal gene transfer during the step-wise genesis of Mycobacterium tuberculosis . BMC Evol Biol 9 : 196. [CrossRef]
5. Tufariello JM,, Kerantzas CA,, Vilchèze C,, Calder RB,, Nordberg EK,, Fischer JA,, Hartman TE,, Yang E,, Driscoll T,, Cole LE,, Sebra R,, Maqbool SB,, Wattam AR,, Jacobs WR Jr . 2015. The complete genome sequence of the emerging pathogen Mycobacterium haemophilum explains its unique culture requirements. MBio 6 : e01313-15. [CrossRef]
6. Le Chevalier F,, Cascioferro A,, Majlessi L,, Herrmann JL,, Brosch R . 2014. Mycobacterium tuberculosis evolutionary pathogenesis and its putative impact on drug development. Future Microbiol 9 : 969 985. [CrossRef]
7. Cole ST,, Brosch R,, Parkhill J,, Garnier T,, Churcher C,, Harris D,, Gordon SV,, Eiglmeier K,, Gas S,, Barry CE III,, Tekaia F,, Badcock K,, Basham D,, Brown D,, Chillingworth T,, Connor R,, Davies R,, Devlin K,, Feltwell T,, Gentles S,, Hamlin N,, Holroyd S,, Hornsby T,, Jagels K,, Krogh A,, McLean J,, Moule S,, Murphy L,, Oliver K,, Osborne J,, Quail MA,, Rajandream MA,, Rogers J,, Rutter S,, Seeger K,, Skelton J,, Squares R,, Squares S,, Sulston JE,, Taylor K,, Whitehead S,, Barrell BG . 1998. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 393 : 537 544. [CrossRef] [CrossRef]
8. Fleischmann RD,, Alland D,, Eisen JA,, Carpenter L,, White O,, Peterson J,, DeBoy R,, Dodson R,, Gwinn M,, Haft D,, Hickey E,, Kolonay JF,, Nelson WC,, Umayam LA,, Ermolaeva M,, Salzberg SL,, Delcher A,, Utterback T,, Weidman J,, Khouri H,, Gill J,, Mikula A,, Bishai W,, Jacobs WR Jr,, Venter JC,, Fraser CM . 2002. Whole-genome comparison of Mycobacterium tuberculosis clinical and laboratory strains. J Bacteriol 184 : 5479 5490. [CrossRef]
9. Roetzer A,, Diel R,, Kohl TA,, Rückert C,, Nübel U,, Blom J,, Wirth T,, Jaenicke S,, Schuback S,, Rüsch-Gerdes S,, Supply P,, Kalinowski J,, Niemann S . 2013. Whole genome sequencing versus traditional genotyping for investigation of a Mycobacterium tuberculosis outbreak: a longitudinal molecular epidemiological study. PLoS Med 10 : e1001387. [CrossRef]
10. Stinear TP,, Seemann T,, Harrison PF,, Jenkin GA,, Davies JK,, Johnson PD,, Abdellah Z,, Arrowsmith C,, Chillingworth T,, Churcher C,, Clarke K,, Cronin A,, Davis P,, Goodhead I,, Holroyd N,, Jagels K,, Lord A,, Moule S,, Mungall K,, Norbertczak H,, Quail MA,, Rabbinowitsch E,, Walker D,, White B,, Whitehead S,, Small PL,, Brosch R,, Ramakrishnan L,, Fischbach MA,, Parkhill J,, Cole ST . 2008. Insights from the complete genome sequenceof Mycobacterium marinum on the evolution of Mycobacterium tuberculosis. Genome Res 18 : 729 741. [CrossRef]
11. Wang J,, McIntosh F,, Radomski N,, Dewar K,, Simeone R,, Enninga J,, Brosch R,, Rocha EP,, Veyrier FJ,, Behr MA . 2015. Insights on the emergence of Mycobacterium tuberculosis from the analysis of Mycobacterium kansasii . Genome Biol Evol 7 : 856 870. [CrossRef]
12. Stinear TP,, Seemann T,, Pidot S,, Frigui W,, Reysset G,, Garnier T,, Meurice G,, Simon D,, Bouchier C,, Ma L,, Tichit M,, Porter JL,, Ryan J,, Johnson PD,, Davies JK,, Jenkin GA,, Small PL,, Jones LM,, Tekaia F,, Laval F,, Daffé M,, Parkhill J,, Cole ST . 2007. Reductive evolution and niche adaptation inferred from the genome of Mycobacterium ulcerans, the causative agent of Buruli ulcer. Genome Res 17 : 192 200. [CrossRef]
13. Singh P,, Benjak A,, Schuenemann VJ,, Herbig A,, Avanzi C,, Busso P,, Nieselt K,, Krause J,, Vera-Cabrera L,, Cole ST . 2015. Insight into the evolution and origin of leprosy bacilli from the genome sequence of Mycobacterium lepromatosis . Proc Natl Acad Sci USA 112 : 4459 4464. [CrossRef] [CrossRef]
14. Cole ST,, Eiglmeier K,, Parkhill J,, James KD,, Thomson NR,, Wheeler PR,, Honoré N,, Garnier T,, Churcher C,, Harris D,, Mungall K,, Basham D,, Brown D,, Chillingworth T,, Connor R,, Davies RM,, Devlin K,, Duthoy S,, Feltwell T,, Fraser A,, Hamlin N,, Holroyd S,, Hornsby T,, Jagels K,, Lacroix C,, Maclean J,, Moule S,, Murphy L,, Oliver K,, Quail MA,, Rajandream MA,, Rutherford KM,, Rutter S,, Seeger K,, Simon S,, Simmonds M,, Skelton J,, Squares R,, Squares S,, Stevens K,, Taylor K,, Whitehead S,, Woodward JR,, Barrell BG . 2001. Massive gene decay in the leprosy bacillus. Nature 409 : 1007 1011. [CrossRef] [CrossRef]
15. Comas I,, Chakravartti J,, Small PM,, Galagan J,, Niemann S,, Kremer K,, Ernst JD,, Gagneux S . 2010. Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved. Nat Genet 42 : 498 503. [CrossRef] [CrossRef]
16. de Jong BC,, Antonio M,, Gagneux S . 2010. Mycobacterium africanum--review of an important cause of human tuberculosis in West Africa. PLoS Negl Trop Dis 4 : e744 [CrossRef] [CrossRef]
17. Gonzalo-Asensio J,, Malaga W,, Pawlik A,, Astarie-Dequeker C,, Passemar C,, Moreau F,, Laval F,, Daffé M,, Martin C,, Brosch R,, Guilhot C . 2014. Evolutionary history of tuberculosis shaped by conserved mutations in the PhoPR virulence regulator. Proc Natl Acad Sci USA 111 : 11491 11496. [CrossRef] [CrossRef]
18. Smith NH,, Kremer K,, Inwald J,, Dale J,, Driscoll JR,, Gordon SV,, van Soolingen D,, Hewinson RG,, Smith JM . 2006. Ecotypes of the Mycobacterium tuberculosis complex. J Theor Biol 239 : 220 225. [CrossRef]
19. Garnier T,, Eiglmeier K,, Camus JC,, Medina N,, Mansoor H,, Pryor M,, Duthoy S,, Grondin S,, Lacroix C,, Monsempe C,, Simon S,, Harris B,, Atkin R,, Doggett J,, Mayes R,, Keating L,, Wheeler PR,, Parkhill J,, Barrell BG,, Cole ST,, Gordon SV,, Hewinson RG . 2003. The complete genome sequence of Mycobacterium bovis . Proc Natl Acad Sci USA 100 : 7877 7882. [CrossRef] [CrossRef]
20. van Ingen J,, Rahim Z,, Mulder A,, Boeree MJ,, Simeone R,, Brosch R,, van Soolingen D . 2012. Characterization of Mycobacterium orygis as M. tuberculosis complex subspecies. Emerg Infect Dis 18 : 653 655. [CrossRef]
21. Parsons SD,, Drewe JA,, Gey van Pittius NC,, Warren RM,, van Helden PD . 2013. Novel cause of tuberculosis in meerkats, South Africa. Emerg Infect Dis 19 : 2004 2007. [CrossRef] [CrossRef]
22. Cousins DV,, Bastida R,, Cataldi A,, Quse V,, Redrobe S,, Dow S,, Duignan P,, Murray A,, Dupont C,, Ahmed N,, Collins DM,, Butler WR,, Dawson D,, Rodríguez D,, Loureiro J,, Romano MI,, Alito A,, Zumarraga M,, Bernardelli A . 2003. Tuberculosis in seals caused by a novel member of the Mycobacterium tuberculosis complex: Mycobacterium pinnipedii sp. nov. Int J Syst Evol Microbiol 53 : 1305 1314. [CrossRef] [CrossRef]
23. Domogalla J,, Prodinger WM,, Blum H,, Krebs S,, Gellert S,, Müller M,, Neuendorf E,, Sedlmaier F,, Büttner M . 2013. Region of difference 4 in alpine Mycobacterium caprae isolates indicates three variants. J Clin Microbiol 51 : 1381 1388. [CrossRef] [CrossRef]
24. Coscolla M,, Lewin A,, Metzger S,, Maetz-Rennsing K,, Calvignac-Spencer S,, Nitsche A,, Dabrowski PW,, Radonic A,, Niemann S,, Parkhill J,, Couacy-Hymann E,, Feldman J,, Comas I,, Boesch C,, Gagneux S,, Leendertz FH . 2013. Novel Mycobacterium tuberculosis complex isolate from a wild chimpanzee. Emerg Infect Dis 19 : 969 976. [CrossRef] [CrossRef]
25. Alexander KA,, Sanderson CE,, Larsen MH,, Robbe-Austerman S,, Williams MC,, Palmer MV . 2016. Emerging tuberculosis pathogen hijacks social communication behavior in the group-living banded mongoose ( Mungos mungo). MBio 7 : e00281-16.
26. Stead WW . 1997. The origin and erratic global spread of tuberculosis. How the past explains the present and is the key to the future. Clin Chest Med 18 : 65 77. [CrossRef] [CrossRef]
27. Brosch R,, Gordon SV,, Marmiesse M,, Brodin P,, Buchrieser C,, Eiglmeier K,, Garnier T,, Gutierrez C,, Hewinson G,, Kremer K,, Parsons LM,, Pym AS,, Samper S,, van Soolingen D,, Cole ST . 2002. A new evolutionary scenario for the Mycobacterium tuberculosis complex. Proc Natl Acad Sci USA 99 : 3684 3689. [CrossRef] [CrossRef]
28. Mostowy S,, Cousins D,, Brinkman J,, Aranaz A,, Behr MA . 2002. Genomic deletions suggest a phylogeny for the Mycobacterium tuberculosis complex. J Infect Dis 186 : 74 80. [CrossRef] [CrossRef]
29. Smith NH,, Hewinson RG,, Kremer K,, Brosch R,, Gordon SV . 2009. Myths and misconceptions: the origin and evolution of Mycobacterium tuberculosis . Nat Rev Microbiol 7 : 537 544. [CrossRef] [CrossRef]
30. Gutierrez MC,, Brisse S,, Brosch R,, Fabre M,, Omaïs B,, Marmiesse M,, Supply P,, Vincent V . 2005. Ancient origin and gene mosaicism of the progenitor of Mycobacterium tuberculosis . PLoS Pathog 1 : e5 [CrossRef]
31. Blouin Y,, Cazajous G,, Dehan C,, Soler C,, Vong R,, Hassan MO,, Hauck Y,, Boulais C,, Andriamanantena D,, Martinaud C,, Martin É,, Pourcel C,, Vergnaud G . 2014. Progenitor “Mycobacterium canettii” clone responsible for lymph node tuberculosis epidemic, Djibouti. Emerg Infect Dis 20 : 21 28. [CrossRef] [CrossRef]
32. Canetti G . 1970. [Infection caused by atypical mycobacteria and antituberculous immunity.] In French. Lille Med 15 : 280 282.
33. van Soolingen D,, Hoogenboezem T,, de Haas PE,, Hermans PW,, Koedam MA,, Teppema KS,, Brennan PJ,, Besra GS,, Portaels F,, Top J,, Schouls LM,, van Embden JD . 1997. A novel pathogenic taxon of the Mycobacterium tuberculosis complex, Canetti: characterization of an exceptional isolate from Africa. Int J Syst Bacteriol 47 : 1236 1245. [CrossRef]
34. Pfyffer GE,, Auckenthaler R,, van Embden JD,, van Soolingen D . 1998. Mycobacterium canettii, the smooth variant of M. tuberculosis, isolated from a Swiss patient exposed in Africa. Emerg Infect Dis 4 : 631 634. [CrossRef]
35. Koeck JL,, Bernatas JJ,, Gerome P,, Fabre M,, Houmed A,, Herve V,, Teyssou R . 2002. [Epidemiology of resistance to antituberculosis drugs in Mycobacterium tuberculosis complex strains isolated from adenopathies in Djibouti. Prospective study carried out in 1999.] In French. Med Trop 62 : 70 72.
36. Fabre M,, Koeck JL,, Le Flèche P,, Simon F,, Hervé V,, Vergnaud G,, Pourcel C . 2004. High genetic diversity revealed by variable-number tandem repeat genotyping and analysis of hsp65 gene polymorphism in a large collection of “ Mycobacterium canettii” strains indicates that the M. tuberculosis complex is a recently emerged clone of “ M. canettii.” J Clin Microbiol 42 : 3248 3255. [CrossRef] [CrossRef]
37. Fabre M,, Hauck Y,, Soler C,, Koeck JL,, van Ingen J,, van Soolingen D,, Vergnaud G,, Pourcel C . 2010. Molecular characteristics of “ Mycobacterium canettii” the smooth Mycobacterium tuberculosis bacilli. Infect Genet Evol 10 : 1165 1173. [CrossRef]
38. Young JS,, Gormley E,, Wellington EM . 2005. Molecular detection of Mycobacterium bovis and Mycobacterium bovis BCG (Pasteur) in soil. Appl Environ Microbiol 71 : 1946 1952. [CrossRef] [CrossRef]
39. Mba Medie F,, Ben Salah I,, Henrissat B,, Raoult D,, Drancourt M . 2011. Mycobacterium tuberculosis complex mycobacteria as amoeba-resistant organisms. PLoS One 6 : e20499. [CrossRef] [CrossRef]
40. Boritsch EC,, Supply P,, Honoré N,, Seemann T,, Stinear TP,, Brosch R . 2014. A glimpse into the past and predictions for the future: the molecular evolution of the tuberculosis agent. Mol Microbiol 93 : 835 852. [CrossRef]
41. Gopinath K,, Moosa A,, Mizrahi V,, Warner DF . 2013. Vitamin B(12) metabolism in Mycobacterium tuberculosis . Future Microbiol 8 : 1405 1418. [CrossRef] [CrossRef]
42. Comas I,, Coscolla M,, Luo T,, Borrell S,, Holt KE,, Kato-Maeda M,, Parkhill J,, Malla B,, Berg S,, Thwaites G,, Yeboah-Manu D,, Bothamley G,, Mei J,, Wei L,, Bentley S,, Harris SR,, Niemann S,, Diel R,, Aseffa A,, Gao Q,, Young D,, Gagneux S . 2013. Out-of-Africa migration and Neolithic coexpansion of Mycobacterium tuberculosis with modern humans. Nat Genet 45 : 1176 1182. [CrossRef] [CrossRef]
43. Young DB,, Comas I,, de Carvalho LP . 2015. Phylogenetic analysis of vitamin B12-related metabolism in Mycobacterium tuberculosis . Front Mol Biosci 2 : 6 [CrossRef] [CrossRef]
44. Boritsch EC,, Frigui W,, Cascioferro A,, Malaga W,, Etienne G,, Laval G,, Pawlik A,, Le Chevalier F,, Orgeur M,, Ma L,, Bouchier C,, Stinear TP,, Supply P,, Majlessi L,, Daffé M,, Guilhot C,, Brosch R . 2016. pks5-recombination-mediated surface remodelling in Mycobacterium tuberculosis emergence. Nat Microbiol 1 : 15019 [CrossRef] [CrossRef]
45. Bottai D,, Brosch R . 2009. Mycobacterial PE, PPE and ESX clusters: novel insights into the secretion of these most unusual protein families. Mol Microbiol 73 : 325 328. [CrossRef] [CrossRef]
46. Zumbo A,, Palucci I,, Cascioferro A,, Sali M,, Ventura M,, D’Alfonso P,, Iantomasi R,, Di Sante G,, Ria F,, Sanguinetti M,, Fadda G,, Manganelli R,, Delogu G . 2013. Functional dissection of protein domains involved in the immunomodulatory properties of PE_PGRS33 of Mycobacterium tuberculosis . Pathog Dis 69 : 232 239. [CrossRef] [CrossRef]
47. Cascioferro A,, Daleke MH,, Ventura M,, Donà V,, Delogu G,, Palù G,, Bitter W,, Manganelli R . 2011. Functional dissection of the PE domain responsible for translocation of PE_PGRS33 across the mycobacterial cell wall. PLoS One 6 : e27713.[CrossRef] [CrossRef]
48. Talarico S,, Cave MD,, Foxman B,, Marrs CF,, Zhang L,, Bates JH,, Yang Z . 2007. Association of Mycobacterium tuberculosis PE PGRS33 polymorphism with clinical and epidemiological characteristics. Tuberculosis (Edinb) 87 : 338 346. [CrossRef] [CrossRef]
49. Danilchanka O,, Sun J,, Pavlenok M,, Maueröder C,, Speer A,, Siroy A,, Marrero J,, Trujillo C,, Mayhew DL,, Doornbos KS,, Muñoz LE,, Herrmann M,, Ehrt S,, Berens C,, Niederweis M . 2014. An outer membrane channel protein of Mycobacterium tuberculosis with exotoxin activity. Proc Natl Acad Sci USA 111 : 6750 6755. [CrossRef] [CrossRef]
50. Gagneux S,, DeRiemer K,, Van T,, Kato-Maeda M,, de Jong BC,, Narayanan S,, Nicol M,, Niemann S,, Kremer K,, Gutierrez MC,, Hilty M,, Hopewell PC,, Small PM . 2006. Variable host-pathogen compatibility in Mycobacterium tuberculosis . Proc Natl Acad Sci USA 103 : 2869 2873. [CrossRef]
51. Filliol I,, Motiwala AS,, Cavatore M,, Qi W,, Hazbón MH,, Bobadilla del Valle M,, Fyfe J,, García-García L,, Rastogi N,, Sola C,, Zozio T,, Guerrero MI,, León CI,, Crabtree J,, Angiuoli S,, Eisenach KD,, Durmaz R,, Joloba ML,, Rendón A,, Sifuentes-Osornio J,, Ponce de León A,, Cave MD,, Fleischmann R,, Whittam TS,, Alland D . 2006. Global phylogeny of Mycobacterium tuberculosis based on single nucleotide polymorphism (SNP) analysis: insights into tuberculosis evolution, phylogenetic accuracy of other DNA fingerprinting systems, and recommendations for a minimal standard SNP set. J Bacteriol 188 : 759 772. [CrossRef] [CrossRef]
52. Baker L,, Brown T,, Maiden MC,, Drobniewski F . 2004. Silent nucleotide polymorphisms and a phylogeny for Mycobacterium tuberculosis . Emerg Infect Dis 10 : 1568 1577. [CrossRef] [CrossRef]
53. Comas I,, Hailu E,, Kiros T,, Bekele S,, Mekonnen W,, Gumi B,, Tschopp R,, Ameni G,, Hewinson RG,, Robertson BD,, Goig GA,, Stucki D,, Gagneux S,, Aseffa A,, Young D,, Berg S . 2015. Population genomics of Mycobacterium tuberculosis in Ethiopia contradicts the virgin soil hypothesis for human tuberculosis in Sub-Saharan Africa. Curr Biol 25 : 3260 3266. [CrossRef] [CrossRef]
54. Nebenzahl-Guimaraes H,, Yimer SA,, Holm-Hansen C,, de Beer J,, Brosch R,, van Soolingen D . 2016. Genomic characterization of Mycobacterium tuberculosis lineage 7 and a proposed name: “Aethiops vetus.” Microb Genom 2 : [CrossRef] [CrossRef]
55. Blouin Y,, Hauck Y,, Soler C,, Fabre M,, Vong R,, Dehan C,, Cazajous G,, Massoure PL,, Kraemer P,, Jenkins A,, Garnotel E,, Pourcel C,, Vergnaud G . 2012. Significance of the identification in the Horn of Africa of an exceptionally deep branching Mycobacterium tuberculosis clade. PLoS One 7 : e52841. [CrossRef] [CrossRef]
56. Firdessa R,, Berg S,, Hailu E,, Schelling E,, Gumi B,, Erenso G,, Gadisa E,, Kiros T,, Habtamu M,, Hussein J,, Zinsstag J,, Robertson BD,, Ameni G,, Lohan AJ,, Loftus B,, Comas I,, Gagneux S,, Tschopp R,, Yamuah L,, Hewinson G,, Gordon SV,, Young DB,, Aseffa A . 2013. Mycobacterial lineages causing pulmonary and extrapulmonary tuberculosis, Ethiopia. Emerg Infect Dis 19 : 460 463. [CrossRef] [CrossRef]
57. Reiling N,, Homolka S,, Walter K,, Brandenburg J,, Niwinski L,, Ernst M,, Herzmann C,, Lange C,, Diel R,, Ehlers S,, Niemann S . 2013. Clade-specific virulence patterns of Mycobacterium tuberculosis complex strains in human primary macrophages and aerogenically infected mice. MBio 4 : e00250-13. [CrossRef] [CrossRef]
58. Winglee K,, Manson McGuire A,, Maiga M,, Abeel T,, Shea T,, Desjardins CA,, Diarra B,, Baya B,, Sanogo M,, Diallo S,, Earl AM,, Bishai WR . 2016. Whole genome sequencing of Mycobacterium africanum strains from Mali provides insights into the mechanisms of geographic restriction. PLoS Negl Trop Dis 10 : e0004332.[CrossRef] [CrossRef]
59. Coscolla M,, Gagneux S . 2014. Consequences of genomic diversity in Mycobacterium tuberculosis . Semin Immunol 26 : 431 444. [CrossRef] [CrossRef]
60. de Jong BC,, Hill PC,, Aiken A,, Awine T,, Antonio M,, Adetifa IM,, Jackson-Sillah DJ,, Fox A,, Deriemer K,, Gagneux S,, Borgdorff MW,, McAdam KP,, Corrah T,, Small PM,, Adegbola RA . 2008. Progression to active tuberculosis, but not transmission, varies by Mycobacterium tuberculosis lineage in The Gambia. J Infect Dis 198 : 1037 1043. [CrossRef] [CrossRef]
61. Niobe-Eyangoh SN,, Kuaban C,, Sorlin P,, Cunin P,, Thonnon J,, Sola C,, Rastogi N,, Vincent V,, Gutierrez MC . 2003. Genetic biodiversity of Mycobacterium tuberculosis complex strains from patients with pulmonary tuberculosis in Cameroon. J Clin Microbiol 41 : 2547 2553. [CrossRef]
62. Godreuil S,, Torrea G,, Terru D,, Chevenet F,, Diagbouga S,, Supply P,, Van de Perre P,, Carriere C,, Bañuls AL . 2007. First molecular epidemiology study of Mycobacterium tuberculosis in Burkina Faso. J Clin Microbiol 45 : 921 927. [CrossRef] [CrossRef]
63. Koro Koro F,, Kamdem Simo Y,, Piam FF,, Noeske J,, Gutierrez C,, Kuaban C,, Eyangoh SI . 2013. Population dynamics of tuberculous Bacilli in Cameroon as assessed by spoligotyping. J Clin Microbiol 51 : 299 302. [CrossRef] [CrossRef]
64. Asante-Poku A,, Yeboah-Manu D,, Otchere ID,, Aboagye SY,, Stucki D,, Hattendorf J,, Borrell S,, Feldmann J,, Danso E,, Gagneux S . 2015. Mycobacterium africanum is associated with patient ethnicity in Ghana. PLoS Negl Trop Dis 9 : e3370. [CrossRef]
65. Brites D,, Gagneux S . 2012. Old and new selective pressures on Mycobacterium tuberculosis . Infect Genet Evol 12 : 678 685. [CrossRef] [CrossRef]
66. Merker M , , et al . 2015. Evolutionary history and global spread of the Mycobacterium tuberculosis Beijing lineage. Nat Genet 47 : 242 249. [CrossRef] [CrossRef]
67. van Soolingen D,, Qian L,, de Haas PE,, Douglas JT,, Traore H,, Portaels F,, Qing HZ,, Enkhsaikan D,, Nymadawa P,, van Embden JD . 1995. Predominance of a single genotype of Mycobacterium tuberculosis in countries of east Asia. J Clin Microbiol 33 : 3234 3238.
68. Luo T,, Comas I,, Luo D,, Lu B,, Wu J,, Wei L,, Yang C,, Liu Q,, Gan M,, Sun G,, Shen X,, Liu F,, Gagneux S,, Mei J,, Lan R,, Wan K,, Gao Q . 2015. Southern East Asian origin and coexpansion of Mycobacterium tuberculosis Beijing family with Han Chinese. Proc Natl Acad Sci USA 112 : 8136 8141. [CrossRef]
69. Mokrousov I . 2013. Insights into the origin, emergence, and current spread of a successful Russian clone of Mycobacterium tuberculosis . Clin Microbiol Rev 26 : 342 360. [CrossRef] [CrossRef]
70. Frieden TR,, Sherman LF,, Maw KL,, Fujiwara PI,, Crawford JT,, Nivin B,, Sharp V,, Hewlett D Jr,, Brudney K,, Alland D,, Kreisworth BN . 1996. A multi-institutional outbreak of highly drug-resistant tuberculosis: epidemiology and clinical outcomes. JAMA 276 : 1229 1235. [CrossRef] [CrossRef]
71. Bifani PJ,, Plikaytis BB,, Kapur V,, Stockbauer K,, Pan X,, Lutfey ML,, Moghazeh SL,, Eisner W,, Daniel TM,, Kaplan MH,, Crawford JT,, Musser JM,, Kreiswirth BN . 1996. Origin and interstate spread of a New York City multidrug-resistant Mycobacterium tuberculosis clone family. JAMA 275 : 452 457. [CrossRef] [CrossRef]
72. Almeida D,, Rodrigues C,, Ashavaid TF,, Lalvani A,, Udwadia ZF,, Mehta A . 2005. High incidence of the Beijing genotype among multidrug-resistant isolates of Mycobacterium tuberculosis in a tertiary care center in Mumbai, India. Clin Infect Dis 40 : 881 886. [CrossRef] [CrossRef]
73. Casali N,, Nikolayevskyy V,, Balabanova Y,, Harris SR,, Ignatyeva O,, Kontsevaya I,, Corander J,, Bryant J,, Parkhill J,, Nejentsev S,, Horstmann RD,, Brown T,, Drobniewski F . 2014. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat Genet 46 : 279 286. [CrossRef] [CrossRef]
74. Coscolla M,, Barry PM,, Oeltmann JE,, Koshinsky H,, Shaw T,, Cilnis M,, Posey J,, Rose J,, Weber T,, Fofanov VY,, Gagneux S,, Kato-Maeda M,, Metcalfe JZ . 2015. Genomic epidemiology of multidrug-resistant Mycobacterium tuberculosis during transcontinental spread. J Infect Dis 212 : 302 310. [CrossRef] [CrossRef]
75. Pfyffer GE,, Strässle A,, van Gorkum T,, Portaels F,, Rigouts L,, Mathieu C,, Mirzoyev F,, Traore H,, van Embden JD . 2001. Multidrug-resistant tuberculosis in prison inmates, Azerbaijan. Emerg Infect Dis 7 : 855 861. [CrossRef] [CrossRef]
76. Johnson R,, Warren RM,, van der Spuy GD,, Gey van Pittius NC,, Theron D,, Streicher EM,, Bosman M,, Coetzee GJ,, van Helden PD,, Victor TC . 2010. Drug-resistant tuberculosis epidemic in the Western Cape driven by a virulent Beijing genotype strain. Int J Tuberc Lung Dis 14 : 119 121.
77. López B,, Aguilar D,, Orozco H,, Burger M,, Espitia C,, Ritacco V,, Barrera L,, Kremer K,, Hernandez-Pando R,, Huygen K,, van Soolingen D . 2003. A marked difference in pathogenesis and immune response induced by different Mycobacterium tuberculosis genotypes. Clin Exp Immunol 133 : 30 37. [CrossRef] [CrossRef]
78. Tsenova L,, Harbacheuski R,, Sung N,, Ellison E,, Fallows D,, Kaplan G . 2007. BCG vaccination confers poor protection against M. tuberculosis HN878-induced central nervous system disease. Vaccine 25 : 5126 5132. [CrossRef] [CrossRef]
79. Parish T,, Smith DA,, Roberts G,, Betts J,, Stoker NG . 2003. The senX3-regX3 two-component regulatory system of Mycobacterium tuberculosis is required for virulence. Microbiology 149 : 1423 1435. [CrossRef] [CrossRef]
80. Marmiesse M,, Brodin P,, Buchrieser C,, Gutierrez C,, Simoes N,, Vincent V,, Glaser P,, Cole ST,, Brosch R . 2004. Macro-array and bioinformatic analyses reveal mycobacterial ‘core’ genes, variation in the ESAT-6 gene family and new phylogenetic markers for the Mycobacterium tuberculosis complex. Microbiology 150 : 483 496. [CrossRef] [CrossRef]
81. Huet G,, Constant P,, Malaga W,, Lanéelle MA,, Kremer K,, van Soolingen D,, Daffé M,, Guilhot C . 2009. A lipid profile typifies the Beijing strains of Mycobacterium tuberculosis: identification of a mutation responsible for a modification of the structures of phthiocerol dimycocerosates and phenolic glycolipids. J Biol Chem 284 : 27101 27113. [CrossRef] [CrossRef]
82. Constant P,, Perez E,, Malaga W,, Lanéelle MA,, Saurel O,, Daffé M,, Guilhot C . 2002. Role of the pks15/1 gene in the biosynthesis of phenolglycolipids in the Mycobacterium tuberculosis complex. Evidence that all strains synthesize glycosylated p-hydroxybenzoic methyl esters and that strains devoid of phenolglycolipids harbor a frameshift mutation in the pks15/1 gene. J Biol Chem 277 : 38148 38158. [CrossRef] [CrossRef]
83. Reed MB,, Domenech P,, Manca C,, Su H,, Barczak AK,, Kreiswirth BN,, Kaplan G,, Barry CE III . 2004. A glycolipid of hypervirulent tuberculosis strains that inhibits the innate immune response. Nature 431 : 84 87. [CrossRef] [CrossRef]
84. Sinsimer D,, Huet G,, Manca C,, Tsenova L,, Koo MS,, Kurepina N,, Kana B,, Mathema B,, Marras SA,, Kreiswirth BN,, Guilhot C,, Kaplan G . 2008. The phenolic glycolipid of Mycobacterium tuberculosis differentially modulates the early host cytokine response but does not in itself confer hypervirulence. Infect Immun 76 : 3027 3036. [CrossRef] [CrossRef]
85. Reed MB,, Gagneux S,, Deriemer K,, Small PM,, Barry CE III . 2007. The W-Beijing lineage of Mycobacterium tuberculosis overproduces triglycerides and has the DosR dormancy regulon constitutively upregulated. J Bacteriol 189 : 2583 2589. [CrossRef] [CrossRef]
86. Fallow A,, Domenech P,, Reed MB . 2010. Strains of the East Asian (W/Beijing) lineage of Mycobacterium tuberculosis are DosS/DosT-DosR two-component regulatory system natural mutants. J Bacteriol 192 : 2228 2238. [CrossRef] [CrossRef]
87. Domenech P,, Kolly GS,, Leon-Solis L,, Fallow A,, Reed MB . 2010. Massive gene duplication event among clinical isolates of the Mycobacterium tuberculosis W/Beijing family. J Bacteriol 192 : 4562 4570. [CrossRef] [CrossRef]
88. Ebrahimi-Rad M,, Bifani P,, Martin C,, Kremer K,, Samper S,, Rauzier J,, Kreiswirth B,, Blazquez J,, Jouan M,, van Soolingen D,, Gicquel B . 2003. Mutations in putative mutator genes of Mycobacterium tuberculosis strains of the W-Beijing family. Emerg Infect Dis 9 : 838 845. [CrossRef] [CrossRef]
89. Merker M,, Kohl TA,, Roetzer A,, Truebe L,, Richter E,, Rüsch-Gerdes S,, Fattorini L,, Oggioni MR,, Cox H,, Varaine F,, Niemann S . 2013. Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients. PLoS One 8 : e82551. [CrossRef]
90. Zhang H,, Li D,, Zhao L,, Fleming J,, Lin N,, Wang T,, Liu Z,, Li C,, Galwey N,, Deng J,, Zhou Y,, Zhu Y,, Gao Y,, Wang T,, Wang S,, Huang Y,, Wang M,, Zhong Q,, Zhou L,, Chen T,, Zhou J,, Yang R,, Zhu G,, Hang H,, Zhang J,, Li F,, Wan K,, Wang J,, Zhang XE,, Bi L . 2013. Genome sequencing of 161 Mycobacterium tuberculosis isolates from China identifies genes and intergenic regions associated with drug resistance. Nat Genet 45 : 1255 1260. [CrossRef] [CrossRef]
91. Ioerger TR,, Feng Y,, Chen X,, Dobos KM,, Victor TC,, Streicher EM,, Warren RM,, Gey van Pittius NC,, Van Helden PD,, Sacchettini JC . 2010. The non-clonality of drug resistance in Beijing-genotype isolates of Mycobacterium tuberculosis from the Western Cape of South Africa. BMC Genomics 11 : 670. [CrossRef]
92. Eldholm V,, Monteserin J,, Rieux A,, Lopez B,, Sobkowiak B,, Ritacco V,, Balloux F . 2015. Four decades of transmission of a multidrug-resistant Mycobacterium tuberculosis outbreak strain. Nat Commun 6 : 7119. [CrossRef]
93. Click ES,, Moonan PK,, Winston CA,, Cowan LS,, Oeltmann JE . 2012. Relationship between Mycobacterium tuberculosis phylogenetic lineage and clinical site of tuberculosis. Clin Infect Dis 54 : 211 219. [CrossRef] [CrossRef]
94. Séraphin MN,, Lauzardo M,, Doggett RT,, Zabala J,, Morris JG Jr,, Blackburn JK . 2016. Spatiotemporal clustering of Mycobacterium tuberculosis complex genotypes in Florida: genetic diversity segregated by country of birth. PLoS One 11 : e0153575. [CrossRef]
95. Anderson J,, Jarlsberg LG,, Grindsdale J,, Osmond D,, Kawamura M,, Hopewell PC,, Kato-Maeda M . 2013. Sublineages of lineage 4 (Euro-American) Mycobacterium tuberculosis differ in genotypic clustering. Int J Tuberc Lung Dis 17 : 885 891. [CrossRef]
96. Lee RS,, Radomski N,, Proulx JF,, Levade I,, Shapiro BJ,, McIntosh F,, Soualhine H,, Menzies D,, Behr MA . 2015. Population genomics of Mycobacterium tuberculosis in the Inuit. Proc Natl Acad Sci USA 112 : 13609 13614. [CrossRef] [CrossRef]
97. Barletta F,, Otero L,, de Jong BC,, Iwamoto T,, Arikawa K,, Van der Stuyft P,, Niemann S,, Merker M,, Uwizeye C,, Seas C,, Rigouts L . 2015. Predominant Mycobacterium tuberculosis families and high rates of recent transmission among new cases are not associated with primary multidrug resistance in Lima, Peru. J Clin Microbiol 53 : 1854 1863. [CrossRef] [CrossRef]
98. Guerra-Assunção JA,, Crampin AC,, Houben RM,, Mzembe T,, Mallard K,, Coll F,, Khan P,, Banda L,, Chiwaya A,, Pereira RP,, McNerney R,, Fine PE,, Parkhill J,, Clark TG,, Glynn JR . 2015. Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area. eLife 4 : e05166.[CrossRef] [CrossRef]
99. Homolka S,, Post E,, Oberhauser B,, George AG,, Westman L,, Dafae F,, Rüsch-Gerdes S,, Niemann S . 2008. High genetic diversity among Mycobacterium tuberculosis complex strains from Sierra Leone. BMC Microbiol 8 : 103. [CrossRef]
100. Brudey K , , et al . 2006. Mycobacterium tuberculosis complex genetic diversity: mining the fourth international spoligotyping database (SpolDB4) for classification, population genetics and epidemiology. BMC Microbiol 6 : 23. [CrossRef]
101. Lazzarini LC,, Spindola SM,, Bang H,, Gibson AL,, Weisenberg S,, da Silva Carvalho W,, Augusto CJ,, Huard RC,, Kritski AL,, Ho JL . 2008. RDRio Mycobacterium tuberculosis infection is associated with a higher frequency of cavitary pulmonary disease. J Clin Microbiol 46 : 2175 2183. [CrossRef] [CrossRef]
102. Lazzarini LC,, Huard RC,, Boechat NL,, Gomes HM,, Oelemann MC,, Kurepina N,, Shashkina E,, Mello FC,, Gibson AL,, Virginio MJ,, Marsico AG,, Butler WR,, Kreiswirth BN,, Suffys PN,, Lapa E Silva JR,, Ho JL . 2007. Discovery of a novel Mycobacterium tuberculosis lineage that is a major cause of tuberculosis in Rio de Janeiro, Brazil. J Clin Microbiol 45 : 3891 3902. [CrossRef] [CrossRef]
103. Gibson AL,, Huard RC,, Gey van Pittius NC,, Lazzarini LC,, Driscoll J,, Kurepina N,, Zozio T,, Sola C,, Spindola SM,, Kritski AL,, Fitzgerald D,, Kremer K,, Mardassi H,, Chitale P,, Brinkworth J,, Garcia de Viedma D,, Gicquel B,, Pape JW,, van Soolingen D,, Kreiswirth BN,, Warren RM,, van Helden PD,, Rastogi N,, Suffys PN,, Lapa e Silva J,, Ho JL . 2008. Application of sensitive and specific molecular methods to uncover global dissemination of the major RDRio Sublineage of the Latin American-Mediterranean Mycobacterium tuberculosis spoligotype family. J Clin Microbiol 46 : 1259 1267. [CrossRef] [CrossRef]
104. Weisenberg SA,, Gibson AL,, Huard RC,, Kurepina N,, Bang H,, Lazzarini LC,, Chiu Y,, Li J,, Ahuja S,, Driscoll J,, Kreiswirth BN,, Ho JL . 2012. Distinct clinical and epidemiological features of tuberculosis in New York City caused by the RD(Rio) Mycobacterium tuberculosis sublineage. Infect Genet Evol 12 : 664 670. [CrossRef]
105. Majlessi L,, Prados-Rosales R,, Casadevall A,, Brosch R . 2015. Release of mycobacterial antigens. Immunol Rev 264 : 25 45. [CrossRef] [CrossRef]
106. Von Groll A,, Martin A,, Felix C,, Prata PF,, Honscha G,, Portaels F,, Vandame P,, da Silva PE,, Palomino JC . 2010. Fitness study of the RDRio lineage and Latin American-Mediterranean family of Mycobacterium tuberculosis in the city of Rio Grande, Brazil. FEMS Immunol Med Microbiol 58 : 119 127. [CrossRef]
107. Kremer K,, van Soolingen D,, Frothingham R,, Haas WH,, Hermans PW,, Martín C,, Palittapongarnpim P,, Plikaytis BB,, Riley LW,, Yakrus MA,, Musser JM,, van Embden JD . 1999. Comparison of methods based on different molecular epidemiological markers for typing of Mycobacterium tuberculosis complex strains: interlaboratory study of discriminatory power and reproducibility. J Clin Microbiol 37 : 2607 2618.
108. Ritacco V,, Di Lonardo M,, Reniero A,, Ambroggi M,, Barrera L,, Dambrosi A,, Lopez B,, Isola N,, de Kantor IN . 1997. Nosocomial spread of human immunodeficiency virus-related multidrug-resistant tuberculosis in Buenos Aires. J Infect Dis 176 : 637 642. [CrossRef]
109. Palmero D,, Ritacco V,, Ambroggi M,, Natiello M,, Barrera L,, Capone L,, Dambrosi A,, di Lonardo M,, Isola N,, Poggi S,, Vescovo M,, Abbate E . 2003. Multidrug-resistant tuberculosis in HIV-negative patients, Buenos Aires, Argentina. Emerg Infect Dis 9 : 965 969. [CrossRef] [CrossRef]
110. Kubín M,, Havelková M,, Hyncicová I,, Svecová Z,, Kaustová J,, Kremer K,, van Soolingen D . 1999. A multidrug-resistant tuberculosis microepidemic caused by genetically closely related Mycobacterium tuberculosis strains. J Clin Microbiol 37 : 2715 2716.
111. Mardassi H,, Namouchi A,, Haltiti R,, Zarrouk M,, Mhenni B,, Karboul A,, Khabouchi N,, Gey van Pittius NC,, Streicher EM,, Rauzier J,, Gicquel B,, Dellagi K . 2005. Tuberculosis due to resistant Haarlem strain, Tunisia. Emerg Infect Dis 11 : 957 961. [CrossRef] [CrossRef]
112. Ramazanzadeh R,, Roshani D,, Shakib P,, Rouhi S . 2015. Prevalence and occurrence rate of Mycobacterium tuberculosis Haarlem family multi-drug resistant in the worldwide population: A systematic review and meta-analysis. J Res Med Sci 20 : 78 88.
113. Olano J,, López B,, Reyes A,, Lemos MP,, Correa N,, Del Portillo P,, Barrera L,, Robledo J,, Ritacco V,, Zambrano MM . 2007. Mutations in DNA repair genes are associated with the Haarlem lineage of Mycobacterium tuberculosis independently of their antibiotic resistance. Tuberculosis (Edinb) 87 : 502 508. [CrossRef] Edinb [CrossRef]
114. Mortimer TD,, Pepperell CS . 2014. Genomic signatures of distributive conjugal transfer among mycobacteria. Genome Biol Evol 6 : 2489 2500. [CrossRef] [CrossRef]
115. Gray TA,, Krywy JA,, Harold J,, Palumbo MJ,, Derbyshire KM . 2013. Distributive conjugal transfer in mycobacteria generates progeny with meiotic-like genome-wide mosaicism, allowing mapping of a mating identity locus. PLoS Biol 11 : e1001602.[CrossRef]
116. Boritsch EC,, Khanna V,, Pawlik A,, Honoré N,, Navas VH,, Ma L,, Bouchier L,, Seemann T,, Supply P,, Stinear TP,, Brosch R . Key experimental evidence of chromosomal DNA transfer among selected tuberculosis-causing mycobacteria. Proc Natl Acad Sci USA 113 : 9876 9881.[CrossRef] [CrossRef]
117. Schatz A,, Waksman SA . 1944. Effect of streptomycin and other antibiotic substances upon Mycobacterium tuberculosis and related organisms. Proc Soc Exp Biol Med 57 : 244 248. [CrossRef] [CrossRef]
118. Medical Research Council . 1952. Treatment of pulmonary tuberculosis with isoniazid; an interim report to the Medical Research Council by their Tuberculosis Chemotherapy Trials Committee. BMJ 2 : 735746. [CrossRef] [CrossRef]
119. Sensi P . 1983. History of the development of rifampin. Rev Infect Dis 5( Suppl 3) : S402 S406. [CrossRef] [CrossRef]
120. Canetti G . 1965. Present aspects of bacterial resistance in tuberculosis. Am Rev Respir Dis 92 : 687 703.
121. Lienhardt C,, Vernon A,, Raviglione MC . 2010. New drugs and new regimens for the treatment of tuberculosis: review of the drug development pipeline and implications for national programmes. Curr Opin Pulm Med 16 : 186 193.[CrossRef]
122. Gardy JL,, Johnston JC,, Ho Sui SJ,, Cook VJ,, Shah L,, Brodkin E,, Rempel S,, Moore R,, Zhao Y,, Holt R,, Varhol R,, Birol I,, Lem M,, Sharma MK,, Elwood K,, Jones SJ,, Brinkman FS,, Brunham RC,, Tang P . 2011. Whole-genome sequencing and social-network analysis of a tuberculosis outbreak. N Engl J Med 364 : 730 739. [CrossRef] [CrossRef]
123. Mitruka K,, Oeltmann JE,, Ijaz K,, Haddad MB . 2011. Tuberculosis outbreak investigations in the United States, 2002–2008. Emerg Infect Dis 17 : 425 431. [CrossRef] [CrossRef]
124. Gandhi NR,, Moll A,, Sturm AW,, Pawinski R,, Govender T,, Lalloo U,, Zeller K,, Andrews J,, Friedland G . 2006. Extensively drug-resistant tuberculosis as a cause of death in patients co-infected with tuberculosis and HIV in a rural area of South Africa. Lancet 368 : 1575 1580. [CrossRef] [CrossRef]
125. Stucki D,, Ballif M,, Bodmer T,, Coscolla M,, Maurer AM,, Droz S,, Butz C,, Borrell S,, Längle C,, Feldmann J,, Furrer H,, Mordasini C,, Helbling P,, Rieder HL,, Egger M,, Gagneux S,, Fenner L . 2015. Tracking a tuberculosis outbreak over 21 years: strain-specific single-nucleotide polymorphism typing combined with targeted whole-genome sequencing. J Infect Dis 211 : 1306 1316.
126. Centers for Disease Control and Prevention (CDC) . 2006. Emergence of Mycobacterium tuberculosis with extensive resistance to second-line drugs--worldwide, 2000–2004. MMWR Morb Mortal Wkly Rep 55 : 301305.
127. WHO . 2015. Global Tuberculosis Report 2015. World Health Organization, Geneva, Switzerland.
128. Telenti A,, Imboden P,, Marchesi F,, Matter L,, Schopfer K,, Bodmer T,, Lowrie D,, Colston MJ,, Cole S . 1993. Detection of rifampicin-resistance mutations in Mycobacterium tuberculosis . Lancet 341 : 647 651. [CrossRef] [CrossRef]
129. Gagneux S,, Long CD,, Small PM,, Van T,, Schoolnik GK,, Bohannan BJ . 2006. The competitive cost of antibiotic resistance in Mycobacterium tuberculosis . Science 312 : 1944 1946. [CrossRef] [CrossRef]
130. Meftahi N,, Namouchi A,, Mhenni B,, Brandis G,, Hughes D,, Mardassi H . 2016. Evidence for the critical role of a secondary site rpoB mutation in the compensatory evolution and successful transmission of an MDR tuberculosis outbreak strain. J Antimicrob Chemother 71 : 324 332. [CrossRef] [CrossRef]
131. Brandis G,, Pietsch F,, Alemayehu R,, Hughes D . 2015. Comprehensive phenotypic characterization of rifampicin resistance mutations in Salmonella provides insight into the evolution of resistance in Mycobacterium tuberculosis . J Antimicrob Chemother 70 : 680 685. [CrossRef] [CrossRef]
132. Zhang Y,, Heym B,, Allen B,, Young D,, Cole S . 1992. The catalase-peroxidase gene and isoniazid resistance of Mycobacterium tuberculosis . Nature 358 : 591 593. [CrossRef] [CrossRef]
133. Cade CE,, Dlouhy AC,, Medzihradszky KF,, Salas-Castillo SP,, Ghiladi RA . 2010. Isoniazid-resistance conferring mutations in Mycobacterium tuberculosis KatG: catalase, peroxidase, and INH-NADH adduct formation activities. Protein Sci 19 : 458 474.
134. Ghiladi RA,, Medzihradszky KF,, Rusnak FM,, Ortiz de Montellano PR . 2005. Correlation between isoniazid resistance and superoxide reactivity in mycobacterium tuberculosis KatG. J Am Chem Soc 127 : 13428 13442. [CrossRef] [CrossRef]
135. Shoeb HA,, Bowman BU Jr,, Ottolenghi AC,, Merola AJ . 1985. Peroxidase-mediated oxidation of isoniazid. Antimicrob Agents Chemother 27 : 399 403. [CrossRef] [CrossRef]
136. Banerjee A,, Dubnau E,, Quemard A,, Balasubramanian V,, Um KS,, Wilson T,, Collins D,, de Lisle G,, Jacobs WR Jr . 1994. inhA, a gene encoding a target for isoniazid and ethionamide in Mycobacterium tuberculosis . Science 263 : 227 230. [CrossRef] [CrossRef]
137. Manca C,, Paul S,, Barry CE III,, Freedman VH,, Kaplan G . 1999. Mycobacterium tuberculosis catalase and peroxidase activities and resistance to oxidative killing in human monocytes in vitro. Infect Immun 67 : 74 79.
138. Middlebrook G,, Cohn ML . 1953. Some observations on the pathogenicity of isoniazid-resistant variants of tubercle bacilli. Science 118 : 297 299. [CrossRef] [CrossRef]
139. Li Z,, Kelley C,, Collins F,, Rouse D,, Morris S . 1998. Expression of katG in Mycobacterium tuberculosis is associated with its growth and persistence in mice and guinea pigs. J Infect Dis 177 : 1030 1035. [CrossRef] [CrossRef]
140. Pym AS,, Saint-Joanis B,, Cole ST . 2002. Effect of katG mutations on the virulence of Mycobacterium tuberculosis and the implication for transmission in humans. Infect Immun 70 : 4955 4960. [CrossRef] [CrossRef]
141. Sherman DR,, Mdluli K,, Hickey MJ,, Arain TM,, Morris SL,, Barry CE III,, Stover CK . 1996. Compensatory ahpC gene expression in isoniazid-resistant Mycobacterium tuberculosis . Science 272 : 1641 1643. [CrossRef] [CrossRef]
142. Guo H,, Seet Q,, Denkin S,, Parsons L,, Zhang Y . 2006. Molecular characterization of isoniazid-resistant clinical isolates of Mycobacterium tuberculosis from the USA. J Med Microbiol 55 : 1527 1531. [CrossRef] [CrossRef]
143. Safi H,, Lingaraju S,, Amin A,, Kim S,, Jones M,, Holmes M,, McNeil M,, Peterson SN,, Chatterjee D,, Fleischmann R,, Alland D . 2013. Evolution of high-level ethambutol-resistant tuberculosis through interacting mutations in decaprenylphosphoryl-β-D-arabinose biosynthetic and utilization pathway genes. Nat Genet 45 : 1190 1197. [CrossRef]
144. Eldholm V,, Balloux F . 2016. Antimicrobial resistance in Mycobacterium tuberculosis: the odd one out. Trends Microbiol 24 : 637 648. [CrossRef] [CrossRef]
145. Frieden TR,, Sterling T,, Pablos-Mendez A,, Kilburn JO,, Cauthen GM,, Dooley SW . 1993. The emergence of drug-resistant tuberculosis in New York City. N Engl J Med 328 : 521 526. [CrossRef] [CrossRef]
146. Rullán JV,, Herrera D,, Cano R,, Moreno V,, Godoy P,, Peiró EF,, Castell J,, Ibañez C,, Ortega A,, Agudo LS,, Pozo F . 1996. Nosocomial transmission of multidrug-resistant Mycobacterium tuberculosis in Spain. Emerg Infect Dis 2 : 125 129. [CrossRef]
147. Hannan MM,, Peres H,, Maltez F,, Hayward AC,, Machado J,, Morgado A,, Proenca R,, Nelson MR,, Bico J,, Young DB,, Gazzard BS . 2001. Investigation and control of a large outbreak of multi-drug resistant tuberculosis at a central Lisbon hospital. J Hosp Infect 47 : 91 97. [CrossRef] [CrossRef]
148. Harries AD,, Kamenya A,, Namarika D,, Msolomba IW,, Salaniponi FM,, Nyangulu DS,, Nunn P . 1997. Delays in diagnosis and treatment of smear-positive tuberculosis and the incidence of tuberculosis in hospital nurses in Blantyre, Malawi. Trans R Soc Trop Med Hyg 91 : 15 17. [CrossRef] [CrossRef]
149. Cohen KA,, Abeel T,, Manson McGuire A,, Desjardins CA,, Munsamy V,